Active Pharmaceutical Ingredient (API) Prequalified
M
Molnupiravir manufactured by Aurore Life Sciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
News
Active Pharmaceutical Ingredient (API) Prequalified
M
Tranexamic acid manufactured by Ami Lifesciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
Shanghai Fosun’s nirmatrelvir + ritonavir tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Indoco’s chewable albendazole tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Shijiazhuang Lonzeal’s tenofovir disoproxil against hepatitis prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Swiss Pharma Nigeria’s sulfadoxine/pyimethamine tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Lupin’s rifampicin/isoniazid/pyrazinamide dispersible tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First chewable albendazole prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Workshop for African manufacturers of HIV RDTs
IVD
WHO Member States are increasingly stepping up to increase human resources and manufacturing capacities for local production.
Emcure’s dolutegravir/lamivudine/tenofovir tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Lupin’s rifapentine tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Shanghai Fosun’s molnupiravir capsule prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Shanghai Desano’s molnupiravir capsule prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO prequalifies the first self-test for hepatitis C virus
IVD
10 July 2024 – The World Health Organization (WHO) has preq
Shanghai Desano's ritonavir tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Reyoung Pharmaceutical's sulfamethoxazole/trimethoprim tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
WHO PQT-IVD Webinar – New Applicants to IVD Prequalification, 26 June 2024
IVD
A webinar for IVD manufacturers was held on 26 June.
Two PQT Medicines workshops for manufacturers
M
The PQT Medicines 7th Annual Medicines Quality Workshop for Manufacturers will take place from 23 to 26 September 2024.
REGISTRATION OPEN: 2024 annual joint UNICEF-UNFPA-WHO meeting with manufacturers and suppliers
IVD
Dear Colleagues,
WHO PQT-IVD Webinar – Product Dossier Assessment
IVD
A webinar for IVD manufacturers was held on We
Performance evaluations for IVDs for monitoring of blood glucose in capillary blood and HbA1c PoC Assays
IVD
On 12 April 2024 WHO announced the expansion of prequalification of in vitro diagnostics to include diabetes.
Macleods’ artesunate 120 mg for injection prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Mylan’s molnupiravir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Request for Proposals: Support to the WHO Immunization and Equipment Pre-qualification Team
ID
The WHO Immunization and Equipment Pre-qualification Team is seeking to enter into a contractual agreement with a successful bidder to implement the following work packages:
S Kant’s sulfadoxine/pyrimethamine tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
22nd Invitation to Manufacturers of Antituberculosis Medicines to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit
M
The Invitation to Manufacturers of Antituberculosis Medicines to su
Ipca’s pyrimethamine/sulfadoxine dispersible tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Ipca’s pyrimethamine/sulfadoxine dispersible tabl + amodiaquine dispersible tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list: